Spire Wealth Management Myriad Genetics Inc Transaction History

Spire Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$16.45 - $25.88 $3,125 - $4,917	190 New	190 $3,000
Q1 2022 Apr 18, 2022	SELL	$22.67 - $28.01 $39,445 - $48,737	-1,740 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$24.13 - $32.63 $41,986 - $56,776	1,740 New	1,740 $48,000
Q2 2021 Jul 26, 2021	SELL	$25.39 - $32.61 $49,510 - $63,589	-1,950 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$19.92 - $31.6 $38,844 - $61,620	1,950 New	1,950 $59,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.09B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.